Horizon Kinetics Asset Management LLC Sells 3,923 Shares of CME Group Inc. $CME

Horizon Kinetics Asset Management LLC lessened its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 1.4% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 279,851 shares of the financial services provider’s stock after selling 3,923 shares during the period. CME Group makes up approximately 1.0% of Horizon Kinetics Asset Management LLC’s portfolio, making the stock its 15th biggest position. Horizon Kinetics Asset Management LLC’s holdings in CME Group were worth $73,315,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Texas Yale Capital Corp. increased its holdings in CME Group by 11.6% in the 3rd quarter. Texas Yale Capital Corp. now owns 12,630 shares of the financial services provider’s stock worth $3,309,000 after purchasing an additional 1,314 shares in the last quarter. Ilmarinen Mutual Pension Insurance Co raised its position in CME Group by 29.8% in the third quarter. Ilmarinen Mutual Pension Insurance Co now owns 94,238 shares of the financial services provider’s stock valued at $24,688,000 after purchasing an additional 21,627 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. raised its position in CME Group by 7,833.3% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 238 shares of the financial services provider’s stock valued at $62,000 after purchasing an additional 235 shares during the last quarter. Sumitomo Life Insurance Co. raised its position in CME Group by 2.3% in the third quarter. Sumitomo Life Insurance Co. now owns 56,333 shares of the financial services provider’s stock valued at $14,758,000 after purchasing an additional 1,268 shares during the last quarter. Finally, Mayflower Financial Advisors LLC boosted its stake in shares of CME Group by 0.7% during the third quarter. Mayflower Financial Advisors LLC now owns 8,042 shares of the financial services provider’s stock valued at $2,107,000 after purchasing an additional 55 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on CME. CLSA set a $367.00 price target on CME Group in a report on Thursday, October 22nd. TD Cowen upped their price objective on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, October 5th. Wells Fargo & Company raised their price objective on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a report on Thursday, October 22nd. Morgan Stanley boosted their target price on shares of CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Finally, Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $314.44.

Check Out Our Latest Stock Analysis on CME

CME Group Price Performance

Shares of CME opened at $307.54 on Friday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $110.08 billion, a price-to-earnings ratio of 25.23, a price-to-earnings-growth ratio of 3.90 and a beta of 0.15. The business has a 50-day moving average of $289.43 and a 200-day moving average of $282.08.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. During the same period in the previous year, the firm earned $2.68 earnings per share. The firm’s quarterly revenue was up 10.6% on a year-over-year basis. As a group, equities research analysts anticipate that CME Group Inc. will post 12.36 earnings per share for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 42.66%.

Insider Activity

In other news, CEO Terrence A. Duffy sold 27,000 shares of the company’s stock in a transaction on Wednesday, November 18th. The shares were sold at an average price of $309.57, for a total value of $8,358,390.00. Following the sale, the chief executive officer directly owned 35,442 shares of the company’s stock, valued at approximately $10,971,779.94. This represents a 43.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Julie Winkler sold 10,079 shares of the stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the sale, the insider owned 21,482 shares of the company’s stock, valued at approximately $6,555,232.30. This trade represents a 31.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 61,166 shares of company stock worth $18,276,512. 0.30% of the stock is owned by insiders.

Recent CME Group Headlines

These are some of the CME headlines that stood out recently:

  • Positive Sentiment: CME reported that XRP and Micro XRP futures generated $81.2 billion in notional volume across roughly 18 months, averaging $216 million per day through mid-November. Strong activity may support transaction and clearing revenue. Article
  • Positive Sentiment: CME’s latest reported quarter beat analyst expectations: earnings were $3.02 per share versus a $2.99 consensus, while revenue of $1.74 billion exceeded estimates and grew 10.6% year over year. Article
  • Neutral Sentiment: A report highlights exchange operators’ potential exposure to AI-driven trading, but provides no specific new CME business or financial update. Article

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.